EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modulation of NF-κB pathway in cancer therapy by sodium butyrate and Isoproterenol

Khushboo Singhal, Malya, Helianthous Verma, Brij Bharti

Molecular Biology Reports · 2025-12 · 52 (1)

DOI: 10.1007/s11033-025-11047-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 22.09.2025. Verfasst von Khushboo Singhal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of life science, JCBOSEUST, Faridabad, Haryana, 121006, India. Hauptthemen laut MEDLINE: NF-kappa B, Isoproterenol, Neoplasms, Butyric Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: NA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nuclear factor kappa B (NF-κB) is a transcriptional factor that regulates inflammation, cell survival, proliferation, and metastasis. In cancer, NF-κB remains persistently activated, contributing to tumor initiation, progression, immune evasion, and therapeutic resistance- making it a viable therapeutic target for intervention. Sodium butyrate (NaB), a short chain fatty acid produced by gut microbiota, is a potent histone deacetylase (HDAC) inhibitor that enhances histone acetylation and alters gene expression. It plays a pivotal role in chromatin remodeling and and reactivating of tumor suppression genes silenced by mutations. Isoproterenol (ISO), a synthetic β-adrenergic receptor agonist, is used in cardiovascular therapy and modulate NF-κB activation. This review highlights the potential of NaB and ISO in inhibiting NF-κB–driven tumor growth and chemoresistance. We also discuss challenges and future directions for integrating biology and bioinformatics to optimize NF-κB-targeted therapies. Our synthesis offers a new perspective on repurposing metabolic and adrenergic modulators for cancer treatment by emphasizing the translational relevance of NF-κB pathway inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BIsoproterenolNeoplasmsButyric AcidHumansSignal TransductionAnimalsGene Expression Regulation, NeoplasticHistone Deacetylase Inhibitors

Stichwörter der Autor:innen

Anti-inflammatoryCancerEpigeneticsIsoproterenolNF-κBSodium butyrateΒ-adrenergic

Substanzen

NF-kappa BIsoproterenolButyric AcidHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Department of life science, JCBOSEUST, Faridabad, Haryana, 121006, India.
  • Department of Zoology, Ramjas college, University of Delhi, Delhi, 110007, India.
  • Department of life science, JCBOSEUST, Faridabad, Haryana, 121006, India. brijbharti@jcboseust.ac.in.

Förderung

  • NA

Zitieren

APA

Singhal, K., Malya, Verma, H., & Bharti, B. (2025). Modulation of NF-κB pathway in cancer therapy by sodium butyrate and Isoproterenol. Molecular Biology Reports, 52(1). https://doi.org/10.1007/s11033-025-11047-4

Vancouver

Singhal K, Malya, Verma H, Bharti B. Modulation of NF-κB pathway in cancer therapy by sodium butyrate and Isoproterenol. Molecular Biology Reports. 2025;52(1). doi:10.1007/s11033-025-11047-4

BibTeX
@article{Singhal2025,
  author = {Singhal, Khushboo and Malya and Verma, Helianthous and Bharti, Brij},
  title = {Modulation of NF-κB pathway in cancer therapy by sodium butyrate and Isoproterenol},
  journal = {Molecular Biology Reports},
  year = {2025},
  volume = {52},
  number = {1},
  doi = {10.1007/s11033-025-11047-4}
}
Kostenlos starten →